body,type,exact_answer,predicted_answers,TP,FP,FN
Are there any tools that could predict protein structure considering amino acid sequence?,list,"[['AlphaFold'], ['PredictProtein', 'predictprotein'], ['PSIPRED', 'PSIPRED Workbench'], ['Jpred', 'jpred'], ['Porter', 'PaleAle 4.0', 'porter 4.0', 'PaleAle'], ['Jnet', 'jnet algorithm']]","[['Distill'], ['PREDICT-2ND'], ['PEP-FOLD'], ['Jnet'], ['deep learning'], ['Porter'], ['PROSPECT'], ['PreSSAPro'], ['SPEED'], ['resource']]",?,?,?
Which proteins does p110α interact with?,list,"[['p85α', 'p85'], ['RAS', 'ras']]","[['RAS'], ['PI3K'], ['p85']]",?,?,?
Which are the types of cancer that c-Myc is associated with?,list,"[['Breast cancer', 'breast cancer'], ['Non-small-cell lung cancer', 'NSCLC'], ['Pancreatic ductal adenocarcinoma', 'pda']]","[[""Burkitt's lymphoma""], ['breast cancer'], ['thyroid cancer'], ['glioma'], ['breast cancers'], ['small cell lung cancer'], ['squamous carcinomas']]",?,?,?
Which pathways are involved in cellular senescence?,list,"[['Activation of the p53/p21 tumor suppressor pathway'], ['Activation of the p16/pRB tumor suppressor pathway']]","[['p53/p21WAF1/CIP1'], ['signaling']]",?,?,?
Which are the components that evaluate druglikeness?,list,"[['No more than 5 hydrogen bond donors', 'H-bond donors'], ['No more than 10 hydrogen bond acceptors', 'H-bond acceptors'], ['A molecular mass less than 500 daltons', 'molecular weight', 'MWT'], ['An octanol-water partition coefficient (log P) that does not exceed 5', 'MlogP', 'CLogP']]","[['PAMPA'], ['aromatic and non-aromatic rings'], ['pK'], ['RO5'], ['hydrogen acceptors'], ['MWT'], ['bond capacity. For these, extreme values were set, e.g., maximum molecular weight 1500, calculated negative logarithm of the octanol/water partition'], ['octanol-water partition'], ['lead']]",?,?,?
Which small molecules inhibit the c-Myc/Max dimerization?,list,"[['Mycro1', 'Mycro1'], ['Mycro2', 'Mycro2'], ['Mycro3', 'Mycro3'], ['IIA6B17', 'IIA6B17'], ['celastrol', 'celastrol'], ['10058-F4', '10058-F4'], ['10074-G5', '10074-G5'], ['JY-3-094', 'generated an analog, JY-3-094'], ['KJ-Pyr-9', 'KJ-Pyr-9'], ['MYCi361', 'MYCi361'], ['MYCi975', 'MYCi975']]","[['10058-F4'], ['Mycro3'], ['10074-G5'], ['ecule 10074-G5'], ['IIA6B17']]",?,?,?
Which models are used for predicting disease progression in Duchenne Muscular Dystrophy?,list,"[['cumulative distribution function using a non-linear mixed effects approach'], ['nonlinear mixed-effects'], ['latent process models'], ['bayesian models'], ['linear regression model'], ['multiple regression model'], ['multiple logistic regression model'], ['Kaplan-Meier survival analysis'], [""Cox-Snell's proportional risk model""]]","[['CTS'], ['mixed effects'], ['logistic regression'], [""Cox-Snell's""], ['Kaplan Meier'], ['process'], ['biomarkers'], ['linear'], ['previous DMD natural history study'], ['Walk Test']]",?,?,?
For what known mutations is KRAS gene considered to be oncogenic?,list,"[['G12C', 'g12c', 'KRAS G12C', 'kras g12c'], ['G12V', 'g12v', 'KRAS G12V', 'kras g12v'], ['G12D', 'g12d', 'KRAS G12D', 'kras g12d'], ['G12A', 'g12a', 'KRAS G12A', 'kras g12a']]","[['G12S'], ['G12D'], ['G12C'], ['KRASG12D'], ['OES-associated alterations'], ['ERBB2'], ['GG12-13VC'], ['single amino acid substitutions']]",?,?,?
Which proteins does the p85α interact with?,list,"[['p85α', 'p85'], ['p110α', 'p110'], ['p110δ']]","[['c-Cbl, Shc, Grb2'], ['regulatory interactions of p110'], ['p110'], ['p11'], ['homodimerized'], ['homodimeric but not monomeric']]",?,?,?
Computational tools for predicting allosteric pathways in proteins,list,"[['MCPath'], ['MutInf'], ['pySCA'], ['CorrSite'], ['CARDS']]","[['Ohm'], ['MutInf'], ['MONETA'], ['Monte Carlo'], ['SBSMMA'], ['Correlation of All Rotameric and Dynamical States (CARDS) framework'], ['CorrSite'], ['MC'], ['overy. Allosite'], ['MC path generation approach']]",?,?,?
What are the classic signs of a basilar skull fracture?,list,"[['Periorbital ecchymosis', 'Raccoon eyes'], ['Postauricular ecchymosis', 'Retroauricular ecchymosis', 'Battle sign'], ['CSF rhinorrhea or otorrhea', 'Cerebrospinal fluid rhinorrhea or otorrhea', 'Rhinorrhea or otorrhea'], ['Hemotympanum']]","[['ecchymosis'], [""Battle's sign""], ['rhinorrhea'], ['otorrhea'], ['trauma']]",?,?,?
Which biomarkers are currently used for Duchenne Muscular Dystrophy?,list,"[['MRI', 'fat fraction MRI', 'MRI mean T2', 'qMR biomarkers'], ['malate dehydrogenase 2'], ['albumin thiol oxidation'], ['myostatin'], ['Interleukin 1 Receptor-Like 1 Protein', 'ST2'], ['Extracellular dystrophy-associated miRNAs', 'dystromiRs'], ['Troponin I'], ['Creatine kinase', 'CK'], ['miR-499'], ['miR-191-5p'], ['miR-223'], ['miR-208a'], ['miR-206'], ['miR-103a-5p'], ['miR-103a-3p'], ['Serum Ostepontin', 'OPN', 'Ostepontin', 'Serum OPN'], ['Pgam1'], ['Tnni3'], ['Camk2b'], ['Cycs'], ['Adamts5'], ['miR-30c'], ['miR-181a'], ['CNTN1'], ['SMAD3'], ['SIRT2'], ['HSP60'], ['MYBPC1'], ['GITR'], ['Titin'], ['miR-18a/b'], ['miR-498'], ['miR-144'], ['miR-182'], ['miR-23a/b'], ['miR-19a/b'], ['miR-200b/200c/429'], ['miR-124a'], ['MMP-9'], ['GDF-8'], ['FSTN'], ['a component of the DAG complex', 'aDG-N']]","[['miR-206'], ['Myostatin'], ['OPN'], ['miR-499'], ['MRI'], ['Creatine kinase'], ['Pgam1'], ['albumin thiol oxidation'], ['Serum Osteopontin']]",?,?,?
What datasets are available related to Duchenne Muscular Dystrophy?,list,"[['MD STARnet', 'Muscular Dystrophy Surveillance Tracking and Research Network'], ['ImagingDMD'], ['PRO-DMD-01'], ['PRO051-02'], ['D-RSC data', 'Duchenne Regulatory Science Consortium database'], ['Japanese Registry of Muscular Dystrophy (Remudy)', 'Remudy', 'Japanese Registry of Muscular Dystrophy'], ['GSE38417'], ['DuchenneConnect'], ['TREAT NMD'], ['Muscular Dystrophy Association (MDA)', 'MDA Registry', 'Muscular Dystrophy Association Registry'], ['4D-DMD study'], ['Dutch Natural History Survey', 'DNHS'], ['PPMD', 'Parent Project Muscular Dystrophy'], ['GSE64420'], ['DMD Italian Group']]","[['ImagingDMD'], ['Remudy'], ['Gene Expression Omnibus'], ['STARnet'], ['Duchenne Connect'], ['GSE38417'], ['case-control 4D-DMD study'], ['15 clinical trials and studies, 1,505 subjects, 27,252 observations']]",?,?,?
Which vitamin deficiencies may present with neurologic signs or symptoms?,list,"[['Vitamin B12', 'Cobalamin'], ['Vitamin A'], ['Vitamin B1', 'Thiamine', 'Thiamin'], ['Vitamin B6', 'Pyridoxine'], ['Vitamin E'], ['Vitamin D']]","[['vitamin B12'], ['thiamine'], ['vitamin E'], ['vitamin E deficiency'], ['B 12'], ['B6 and D']]",?,?,?
What laboratory abnormalities are commonly seen in patients with COVID-19?,list,"[['Elevated ferritin', 'Increased serum ferritin'], ['Elevated CRP', 'Elevated C-reactive protein', 'High C-reactive protein', 'Elevated high sensitivity C-reactive protein (hs-CRP)'], ['Elevated ESR', 'Increased ESR', 'High erythrocyte sedimentation rate (ESR)'], ['Leucocytosis', 'Increased white blood cells (WBC)', 'Increased polymorphonuclear leukocytes (PMN)'], ['Lymphopenia', 'Decreased lymphocyte count'], ['Elevated aminotransferases', 'Increased alanine aminotransferase (ALT)', 'Increased aspartate aminotransferase (AST)', 'Increased ALT', 'Increased AST'], ['Elevated lactate dehydrogenase (LDH)', 'Elevated lactic dehydrogenase (LDH)', 'Increased LDH'], ['Elevated D-dimers', 'Elevated levels of D-dimer', 'Increased D-Dimer'], ['Increased troponin', 'Elevated troponin', 'Elevated hypersensitive cardiac troponin I (hs-CTnI)'], ['Hyponatremia'], ['Decreased platelet count', 'Decreased platelets'], ['Decreased albumin'], ['Increased procalcitonin (PCT)', 'Elevated procalcitonin'], ['Increased total bilirubin', 'Increased bilirubin'], ['Increased creatinine']]","[['Lymphopenia'], ['lymphopenia'], ['thrombocytopenia'], ['lactate dehydrogenase'], ['IL-6, D-dimer, serum ferritin and lactate dehydrogenase'], ['Increased serum ferritin (74.2%), high C-reactive protein'], ['lymphopenia, thrombocytopenia, and prolonged prothrombin time'], ['platelet']]",?,?,?
